Response to 2026 Review report on the implementation and enforcement of the European Parliament and Council Regulation (EU) 2022/2560 of 14 December 2022 on foreign subsidies distorting the internal market

18 Nov 2025

Meeting with Angelika Niebler (Member of the European Parliament)

13 Nov 2025 · EU Pharmaceutical Policy

Meeting with Eero Heinäluoma (Member of the European Parliament)

13 Nov 2025 · Critical Medicines Act

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on establishing the European Competitiveness Fund ('ECF’), including the specific programme for defence research and innovation activities, repealing Regulations (EU) 2021/522, (EU) 2021/694, (EU) 2021/697, (EU) 2021/783, repealing provisions of Regulations (EU) 2021/696, (EU) 2023/588, and amending Regulation (EU) [EDIP]

12 Nov 2025

Response to Circular Economy Act

5 Nov 2025

Meeting with Kilian Gross (Head of Unit Communications Networks, Content and Technology)

4 Nov 2025 · Exchange of views on the AI Act and how it applies to research and development activities

Meeting with Dorota Denning (Cabinet of Commissioner Valdis Dombrovskis) and 2 other interest representatives

28 Oct 2025 · Roundtable on Simplification for Pharmaceutical Innovation

Meeting with Ingeborg Ter Laak (Member of the European Parliament) and Pharmaceutical Group of the European Union

27 Oct 2025 · CMA & Biotech Act

Meeting with Nicolás González Casares (Member of the European Parliament)

22 Oct 2025 · Critical Medicines Act

Meeting with Aurelijus Veryga (Member of the European Parliament)

22 Oct 2025 · Discussion on the Critical Medicines Act

Meeting with Maya Matthews (Head of Unit Health and Food Safety) and European Confederation of Pharmaceutical Entrepreneurs

22 Oct 2025 · Exchange of views on joint clinical assessment and joint scientific consultations under the HTA Regulation.

Meeting with Agnes Mathieu-Mendes (Head of Unit Health and Food Safety) and Les entreprises du médicament

17 Oct 2025 · Leem & Efpia | Request for a meeting - France's medicines shortages regulatory framework & policies

Meeting with Martin Hojsík (Member of the European Parliament)

17 Oct 2025 · REACH revision

Response to Digital Omnibus revising several legislative acts in view of regulatory simplification

14 Oct 2025

Meeting with Chiara Galiffa (Cabinet of Commissioner Maroš Šefčovič)

9 Oct 2025 · EU – US relations

Meeting with Paul Speight (Head of Unit Environment)

8 Oct 2025 · REACH, latest developments in chemicals

Meeting with Matthias Jorgensen (Acting Director Trade)

7 Oct 2025 · EU-US trade relations

Response to Proposal for a Regulation of the European Parliament and of the Council amending Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on in vitro diagnostic medical devices as regards simplification and burden reduction

6 Oct 2025

Meeting with Olga Solomon (Head of Unit Health and Food Safety) and 10 other interest representatives

3 Oct 2025 · The discussion focused on simplifying Annex II to foster innovation while aligning with ICH guidelines, with ideas for legacy products to gradually transition.

Response to Regulation of the European Parliament and of the Council establishing a framework of measures for strengthening Europe’s innovation ecosystem

2 Oct 2025

Meeting with Olivér Várhelyi (Commissioner) and 29 other attendees

2 Oct 2025 · All pressing portfolio topics

Meeting with Tomislav Sokol (Member of the European Parliament, Rapporteur) and 2 other interest representatives

25 Sept 2025 · Health policy

Response to Commission Communication on a EU Cardiovascular Health Plan

11 Sept 2025

Meeting with Olivér Várhelyi (Commissioner) and 2 other attendees

11 Sept 2025 · Site visit of UCB factory

Meeting with Olivér Várhelyi (Commissioner) and 2 other attendees

11 Sept 2025 · Consumer protection dimension of specific dossiers

Meeting with Mariateresa Vivaldini (Member of the European Parliament, Shadow rapporteur)

10 Sept 2025 · CMA

Meeting with Peter Liese (Member of the European Parliament)

9 Sept 2025 · Austausch

Meeting with Jessika Roswall (Commissioner) and 2 other attendees

1 Sept 2025 · To discuss the REACH revision and discuss the IHI PFAS projects.

Response to Communication on a Strategy for a European Data Union

18 Jul 2025

Meeting with Tiemo Wölken (Member of the European Parliament, Shadow rapporteur) and 3 other interest representatives

17 Jul 2025 · Critical Medicines Act

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795

4 Jul 2025

Meeting with Maya Matthews (Head of Unit Health and Food Safety)

3 Jul 2025 · Discussion on implementation of the HTA Regulation with EFPIA HTA Working Group

Response to Legislative proposal for a Regulation of the European Parliament and of the Council on the Industrial Decarbonisation Accelerator Act

27 Jun 2025

Meeting with Adam Jarubas (Member of the European Parliament, Committee chair)

25 Jun 2025 · Akt o Lekach Krytycznych

Meeting with Sabine Weyand (Director-General Trade)

25 Jun 2025 · Latest global economic developments.

Meeting with Mohammed Chahim (Member of the European Parliament, Shadow rapporteur for opinion) and 14 other interest representatives

25 Jun 2025 · Roundtable Critical Medicines Act

Meeting with Olivér Várhelyi (Commissioner) and 3 other attendees

25 Jun 2025 · Exchange of views on the EU pharma policy

Meeting with Sirpa Pietikäinen (Member of the European Parliament)

23 Jun 2025 · Medicine access

Response to Communication on a new EU Bioeconomy strategy: Towards a Circular, Regenerative and Competitive Bioeconomy

21 Jun 2025

Meeting with Dorota Denning (Cabinet of Commissioner Valdis Dombrovskis), Zaneta Vegnere (Cabinet of Commissioner Valdis Dombrovskis)

19 Jun 2025 · Competitiveness and simplification

Meeting with Tilly Metz (Member of the European Parliament, Shadow rapporteur) and 10 other interest representatives

13 Jun 2025 · Critical Medicines Act

Meeting with Dan-Ştefan Motreanu (Member of the European Parliament)

12 Jun 2025 · Barriers to Accessing and Affording Medicines in Eastern Europe

Response to Proposal for a Regulation of the European Parliament and Council to foster biotechnology in Europe

11 Jun 2025

Meeting with Viktória Ferenc (Member of the European Parliament)

5 Jun 2025 · Introduction, exchange of views

Meeting with Sandra Gallina (Director-General Health and Food Safety) and 1 other attendee

5 Jun 2025 · EU pharmaceutical regulation and policy

Meeting with Marc Lemaitre (Director-General Research and Innovation) and 3 other interest representatives

4 Jun 2025 · 2nd dialogue with representatives from across the life sciences to review the progress of the IHI, to discuss opportunities to optimise the current partnership and to exchange views on the future of EU research and innovation programmes.

Response to Apply AI Strategy: strengthening the AI continent

3 Jun 2025

Response to COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS: A European Strategy for AI in science – paving the way for a European AI research council

3 Jun 2025

Response to Evaluation of EU Directives 2004/9/EC and 2004/10/EC on the Good Laboratory Practice (GLP)

2 Jun 2025

Meeting with Michalis Hadjipantela (Member of the European Parliament)

22 May 2025 · Meeting about PFAS

Meeting with Adam Jarubas (Member of the European Parliament, Committee chair)

20 May 2025 · EU competitiveness agenda opportunities for the European economy and access to healthcare for all EU citizens

Meeting with Ana Maria Blass Rico (Acting Head of Unit Internal Market, Industry, Entrepreneurship and SMEs)

15 May 2025 · Exchange of views on the REACH revision and PFAS

Meeting with Patricia Reilly (Cabinet of President Ursula von der Leyen)

13 May 2025 · Discussion on the pharmaceutical industry Strategic Dialogue

Response to Communication on the EU Stockpiling Strategy

9 May 2025

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions Strategy to support medical countermeasures against public health threats

9 May 2025

Response to Joint communication to the European Parliament and the Council on a comprehensive strategic approach towards India

8 May 2025

Meeting with Hildegard Bentele (Member of the European Parliament)

7 May 2025 · EU Water Policy

Meeting with Aura Salla (Member of the European Parliament)

6 May 2025 · Clean Industrial Deal, chemicals and pharmaceutical industry

Meeting with Aurelijus Veryga (Member of the European Parliament)

6 May 2025 · Balancing environmental goals and pharmaceutical access in EU policy

Meeting with Olivér Várhelyi (Commissioner) and 3 other attendees

30 Apr 2025 · Exchange of views on the EU pharma policy

Meeting with Andreas Glück (Member of the European Parliament, Shadow rapporteur for opinion)

28 Apr 2025 · Critical Medicines

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on the “Strategy for European Life Sciences”

17 Apr 2025

Meeting with Vilija Sysaite (Cabinet of Executive Vice-President Stéphane Séjourné)

14 Apr 2025 · - potential U.S. tariffs on Pharma - upcoming REACH revision and PFAS - European environmental legislation

Meeting with Kerstin Jorna (Director-General Internal Market, Industry, Entrepreneurship and SMEs) and 29 other attendees

10 Apr 2025 · Impact of US tariffs

Meeting with Stéphane Séjourné (Executive Vice-President) and 28 other attendees

10 Apr 2025 · Impact of US tariffs

Meeting with Tomislav Sokol (Member of the European Parliament)

7 Apr 2025 · Health policy

Meeting with Maurice Whelan (Head of Unit Joint Research Centre), Tobias Wiesenthal (Head of Unit Joint Research Centre) and 9 other attendees

4 Apr 2025 · Scientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovation

Meeting with Morten Løkkegaard (Member of the European Parliament, Shadow rapporteur)

3 Apr 2025 · Biotechnology & Simplification

Meeting with Susanne Appel (Cabinet of Commissioner Maria Luís Albuquerque)

3 Apr 2025 · Financing challenges for small enterprises

Response to Guidelines on the assessment of foreign subsidies under the European Parliament and Council Regulation (EU) 2022/2560 of 14 December 2022 on foreign subsidies distorting the internal market

2 Apr 2025

Response to Amendments to Taxonomy Delegated Acts

26 Mar 2025

Response to Targeted evaluation of Regulation (EU)2017/745 on Medical Devices and Regulation (EU)2017/746 on In Vitro Diagnostics

21 Mar 2025

Meeting with Sander Smit (Member of the European Parliament) and Association of the European Self-Care Industry

21 Mar 2025 · ENVI-general

Meeting with Olivér Várhelyi (Commissioner) and 3 other attendees

20 Mar 2025 · Exchange of views on the EU health policy

Meeting with Maroš Šefčovič (Commissioner) and 4 other attendees

20 Mar 2025 · Global trade developments and challenges

Meeting with Patricia Reilly (Cabinet of President Ursula von der Leyen)

20 Mar 2025 · Competitiveness of the EU pharmaceutical industry

Meeting with Vytenis Povilas Andriukaitis (Member of the European Parliament)

19 Mar 2025 · EU Health Policy

Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur) and Novo Nordisk A/S

19 Mar 2025 · New EU Pharmaceutical Legislation

Meeting with Roxana Mînzatu (Executive Vice-President) and 1 other attendee

19 Mar 2025 · Topical issues for the pharmaceutical industry, including competitiveness and skills.

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur)

18 Mar 2025 · SPC, Compulsory Licensing, Pharma Package

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions: European Start-up and Scale-up Strategy

17 Mar 2025

Meeting with Sirpa Pietikäinen (Member of the European Parliament)

14 Mar 2025 · Cancer and ontology

Meeting with Kristoffer Storm (Member of the European Parliament)

12 Mar 2025 · Pharmaceutical Federation

Meeting with Nicolo Brignoli (Cabinet of Commissioner Valdis Dombrovskis)

11 Mar 2025 · taxonomy

Response to Evaluation of Directive 2014/23/EU on the award of concessions contracts, Directive 2014/24/EU on public procurement, and Directive 2014/25/EU on procurement by entities operating in the water, energy, transport and postal services sectors

7 Mar 2025

Meeting with Adam Jarubas (Member of the European Parliament, Committee chair)

6 Mar 2025 · Pharmaceutical strategy for Europe

Meeting with Aurelijus Veryga (Member of the European Parliament)

5 Mar 2025 · The Future of Oncology Research in Europe: Challenges and Opportunities

Response to European Water Resilience Strategy

1 Mar 2025

Response to Critical Medicines Act

26 Feb 2025

Meeting with Vytenis Povilas Andriukaitis (Member of the European Parliament)

19 Feb 2025 · Medicines shortages and critical medicines act

Meeting with Elisa Roller (Director Secretariat-General)

18 Feb 2025 · Competitiveness of the innovative pharmaceutical sector, with specific focus on clinical trials and biotech act.

Response to Single Market Strategy 2025

31 Jan 2025

Meeting with Jorge Vitorino (Head of Unit Trade)

31 Jan 2025 · Discussion on the international aspects of IP policy affecting the pharmaceutical industry

Meeting with Maurice Whelan (Head of Unit Joint Research Centre), Tobias Wiesenthal (Head of Unit Joint Research Centre) and 2 other attendees

27 Jan 2025 · Exploit interest in a scientific roundtable between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovation

Meeting with Marco Marsella (Director Health and Food Safety), Rainer Becker (Director Health and Food Safety)

24 Jan 2025 · AI in medicinal products’ life cycle

Meeting with Stine Bosse (Member of the European Parliament)

17 Jan 2025 · European chemical regulation

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... amending Implementing Regulation (EU) No 520/2012 of 19 June 2012 on the performance of pharmacovigilance activities provided for in Regulation (EC) No 726/2004 of the European Parliament and of the Council and Directive 2001/83/EC of the European Parliament and of the Council

15 Jan 2025

Meeting with Andrea Wechsler (Member of the European Parliament)

15 Jan 2025 · EU Health policy

Meeting with Axel Hellman (Cabinet of Commissioner Jessika Roswall), Jan Ceyssens (Cabinet of Commissioner Jessika Roswall), Vita Jukne (Cabinet of Commissioner Jessika Roswall)

14 Jan 2025 · Chemical Regulation & Water Treatment Directive

Meeting with Teresa Ribera Rodríguez (Executive Vice-President) and 2 other attendees

14 Jan 2025 · Meeting with EFPIA’s Board members on the objectives of the new Commission to build a cleaner and more competitive Europe.

Meeting with Peter Van Kemseke (Cabinet of President Ursula von der Leyen)

11 Dec 2024 · health policies -priorities

Meeting with Olivér Várhelyi (Commissioner)

11 Dec 2024 · Priorities and initiatives concerning pharma industry

Meeting with Adam Jarubas (Member of the European Parliament, Committee chair)

10 Dec 2024 · Pakiet Farmaceutyczny Akt o Lekach Krytycznych Polska Prezydencja

Meeting with Radan Kanev (Member of the European Parliament)

26 Nov 2024 · Sustainability and strategic autonomy of the pharmaceutical sector

Meeting with Mariateresa Vivaldini (Member of the European Parliament) and Meta Platforms Ireland Limited and its various subsidiaries

20 Nov 2024 · Meeting conoscitivo

Meeting with Tilly Metz (Member of the European Parliament)

12 Nov 2024 · Pharmaceutical policy

Meeting with Stine Bosse (Member of the European Parliament, Shadow rapporteur)

5 Nov 2024 · European health policy

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 with regard to the procedures for joint scientific consultations on medicinal products for human use at Union level

29 Oct 2024

Meeting with Victor Negrescu (Member of the European Parliament) and 4 other interest representatives

16 Oct 2024 · European Health Policies and their Impact on CEE Countries and Romania event

Meeting with Stine Bosse (Member of the European Parliament, Committee chair) and European Confederation of Pharmaceutical Entrepreneurs

15 Oct 2024 · European health policy

Response to Commission Roadmap towards ultimately phasing out animal testing for chemical safety assessments

14 Oct 2024

Meeting with Eszter Lakos (Member of the European Parliament) and EuropaBio

25 Sept 2024 · Public health

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 of the European Parliament and of the Council, detailed procedural rules for the cooperation of the Member State Coordination Group on Health Technology Assessment and the Commission with the European Medicines Agency in the form of exchange of information as regards the joint clinical assessment of medicinal products and medical devices and in vitro diagnostic medical devices and as regards the joint scientific consultation on medicinal products and medical devices

24 Jul 2024

Meeting with Tom Berendsen (Member of the European Parliament) and 4 other interest representatives

23 Jul 2024 · Industrial policy

Meeting with Christian Ehler (Member of the European Parliament) and 4 other interest representatives

23 Jul 2024 · Industrial policy

Meeting with Laurent Castillo (Member of the European Parliament)

18 Jul 2024 · Europe de la Santé

Meeting with Lukas Sieper (Member of the European Parliament) and 8 other interest representatives

16 Jul 2024 · Introductory meeting at networking event

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 of the European Parliament and of the Council as regards the management of conflicts of interest in the joint work of the Member State Coordination Group on Health Technology Assessment and its subgroups

26 Jun 2024

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2024/573 of the European Parliament and of the Council as regards the format of the labels for certain products and equipment containing fluorinated greenhouse gases and repealing Commission Implementing Regulation (EU) 2015/2068

4 Jun 2024

Meeting with Pernille Weiss-Ehler (Member of the European Parliament)

21 May 2024 · General discussion

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL establishing a common data platform on chemicals, laying down rules to ensure that the data contained in it are findable, accessible, interoperable and reusable and establishing a monitoring and outlook framework for chemicals

3 Apr 2024

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medicinal products for human use at Union level, as well as templates for those joint clinical assessments

2 Apr 2024

Meeting with Matthias Ecke (Member of the European Parliament) and GSK

28 Mar 2024 · Pharmapaket

Meeting with Katherine Power (Cabinet of Commissioner Mairead Mcguinness), Patricia Reilly (Cabinet of Commissioner Mairead Mcguinness)

21 Mar 2024 · Sanctions

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)

11 Mar 2024 · Directive on Medicinal products for human use

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EC) No 1234/2008 as regards the examination of variations to the terms of marketing authorisations for medicinal products for human use

29 Feb 2024

Meeting with Peter Liese (Member of the European Parliament)

23 Feb 2024 · Austausch

Response to Report on the review of the implementation of the operations of the Health Emergency Preparedness and Response Authority (HERA) pursuant article 8 of the Commission decision c(2021) 6712 of 16 September establishing HERA.

19 Feb 2024

Meeting with Josianne Cutajar (Member of the European Parliament)

19 Feb 2024 · The Pharmaceutical Package

Meeting with Riho Terras (Member of the European Parliament)

19 Feb 2024 · Reform of pharmaceuticals legislation

Meeting with Frédérique Ries (Member of the European Parliament, Shadow rapporteur)

8 Feb 2024 · Revision of the Pharmaceutical Legislation

Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur)

6 Feb 2024 · Pharmaceutical legislation

Meeting with Adam Jarubas (Member of the European Parliament) and 4 other interest representatives

31 Jan 2024 · EU pharmaceutical roundtable - the EU institutions’ representatives and the stakeholder's dialogue

Meeting with Peter Liese (Member of the European Parliament) and 2 other interest representatives

22 Jan 2024 · Austausch

Meeting with Laura Ballarín Cereza (Member of the European Parliament, Shadow rapporteur for opinion)

17 Jan 2024 · Pharmaceutical Legislation (Regulation)

Meeting with Ondřej Knotek (Member of the European Parliament)

13 Dec 2023 · Pharmaceutical package

Meeting with Christel Schaldemose (Member of the European Parliament) and Novo Nordisk A/S

13 Dec 2023 · EU General Pharmaceutical Legislation

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and 8 other interest representatives

12 Dec 2023 · Directive on Medicinal products for human use

Meeting with Henna Virkkunen (Member of the European Parliament, Rapporteur for opinion)

12 Dec 2023 · Medicinal products for human use

Meeting with Javier Zarzalejos (Member of the European Parliament, Shadow rapporteur)

5 Dec 2023 · Meeting with the European Federation of Pharmaceutical Industries (EFPIA) to discuss the Supplementary protection certificates (SPCs) package

Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur)

5 Dec 2023 · Pharmaceutical legislation

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and Bayer AG

10 Nov 2023 · Directive on Medicinal products for human use

Meeting with Javier Zarzalejos (Member of the European Parliament, Shadow rapporteur)

8 Nov 2023 · Meeting with the European Federation of Pharmaceutical Industries (EFPIA) to discuss the Supplementary protection certificates (SPCs) package

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL establishing the Union Customs Code and the European Union Customs Authority, and repealing Regulation (EU) No 952/2013

7 Nov 2023

Meeting with Erik Poulsen (Member of the European Parliament) and 2 other interest representatives

30 Oct 2023 · Pharmaceuticals legislation

Meeting with Laura Ballarín Cereza (Member of the European Parliament, Shadow rapporteur for opinion) and 3 other interest representatives

23 Oct 2023 · Pharmaceutical Package (Regulation)

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and Vaccines Europe

20 Oct 2023 · Directive on Medicinal products for human use

Meeting with Henna Virkkunen (Member of the European Parliament, Rapporteur for opinion) and 2 other interest representatives

20 Oct 2023 · Medicinal products for human use

Response to Commission Delegated Regulation supplementing Directive 2001/83/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council on the examination of variations to the terms of marketing authorisations for medicinal products for human use and amending Commission Regulation (EC) No 1234/2008 of 24 November 2008

25 Sept 2023

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)

22 Sept 2023 · Directive on Medicinal products for human use

Meeting with Margrete Auken (Member of the European Parliament, Shadow rapporteur)

22 Sept 2023 · Pharma legislation

Meeting with Catherine Amalric (Member of the European Parliament, Shadow rapporteur) and 2 other interest representatives

18 Sept 2023 · Reform of the EU pharmaceutical legislation

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the supplementary protection certificate for medicinal products (recast)

15 Sept 2023

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the unitary supplementary certificate for medicinal products, and amending Regulation (EU) 2017/1001, Regulation (EC) No 1901/2006 as well as Regulation (EU) No 608/2013

15 Sept 2023

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and 9 other interest representatives

7 Sept 2023 · Revision of the Pharmaceutical Legislation (staff level)

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)

4 Sept 2023 · Directive on Medicinal products for human use

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on compulsory licensing for crisis management and amending Regulation (EC) 816/2006

28 Jul 2023

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur)

19 Jul 2023 · SPC and Complsory licensing (staff level)

Meeting with Tomislav Sokol (Member of the European Parliament)

11 Jul 2023 · COVI report

Response to COMMISSION DELEGATED REGULATION (EU) …/... supplementing Directive 2013/34/EU of the European Parliament and of the Council as regards sustainability reporting standards

7 Jul 2023

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and AbbVie

13 Jun 2023 · Directive on Medicinal products for human use

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and 2 other interest representatives

7 Jun 2023 · Revision of Pharmaceutical Legislation (staff level)

Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur)

23 May 2023 · Pharmaceutical legislation

Meeting with Karsten Lucke (Member of the European Parliament)

17 May 2023 · R&D

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Delegated Regulation (EU) 2021/2139 as regards additional technical screening criteria for determining the conditions under which certain economic activities qualify as contributing substantially to climate change mitigation or climate change adaptation and for determining whether those activities cause no significant harm to any of the other environmental objectives

2 May 2023

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on packaging and packaging waste, amending Regulation (EU) 2019/1020 and Directive (EU) 2019/904, and repealing Directive 94/62/EC

21 Apr 2023

Meeting with Patricia Reilly (Cabinet of Commissioner Mairead Mcguinness)

3 Apr 2023 · Review of EU pharmaceutical regulations

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures

30 Mar 2023

Meeting with Deirdre Clune (Member of the European Parliament, Shadow rapporteur) and 13 other interest representatives

29 Mar 2023 · Stakeholder Consultation on Urban Waste Water Treatment Directive

Meeting with Despina Spanou (Cabinet of Vice-President Margaritis Schinas), Maria Luisa Llano Cardenal (Cabinet of Vice-President Margaritis Schinas)

21 Mar 2023 · Revision of the pharmaceutical legislation

Meeting with Kevin Keary (Cabinet of Executive Vice-President Valdis Dombrovskis)

17 Mar 2023 · competitiveness, intellectual property protection, FTAs

Meeting with Anthony Whelan (Cabinet of President Ursula von der Leyen)

16 Mar 2023 · Boosting competitiveness and productivity in the EU pharmaceutical industry

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Directive 2000/60/EC establishing a framework for Community action in the field of water policy, Directive 2006/118/EC on the protection of groundwater against pollution and deterioration and Directive 2008/105/EC on environmental quality standards in the field of water policy

14 Mar 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL concerning urban wastewater treatment (recast)

14 Mar 2023

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... on detailed arrangements for the conduct of proceedings by the Commission pursuant to Regulation (EU) 2022/2560 of the European Parliament and of the Council on foreign subsidies distorting the internal market

6 Mar 2023

Meeting with Patricia Reilly (Cabinet of Commissioner Mairead Mcguinness) and 3 other interest representatives

10 Feb 2023 · Discussion of upcoming pharmaceutical package; value of predictability (IP), EU pharmaceutical product approval process, competitiveness, unmet medical needs.

Meeting with Antoine Kasel (Cabinet of Commissioner Nicolas Schmit)

10 Feb 2023 · employment aspects of the upcoming Pharmaceutical legislation

Meeting with Caroline Boeshertz (Cabinet of Executive Vice-President Valdis Dombrovskis), Kevin Keary (Cabinet of Executive Vice-President Valdis Dombrovskis)

9 Feb 2023 · Pharma package, competitiveness

Meeting with Kyriacos Charalambous (Cabinet of Commissioner Johannes Hahn)

8 Feb 2023 · Presenting the industry’s point of view on the upcoming pharmaceutical package and on the wider competitiveness, global positioning and resilience aspects.

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on fees and charges payable to the European Medicines Agency, amending Regulation (EU) 2017/745 of the European Parliament and of the Council and repealing Council Regulation (EC) No 297/95 and Regulation (EU) 658/2014 of the European Parliament and of the Council

6 Feb 2023

Meeting with Patricia Reilly (Cabinet of Commissioner Mairead Mcguinness)

1 Feb 2023 · Discussion of the upcoming pharmaceutical legislative package

Meeting with Sara Cerdas (Member of the European Parliament, Shadow rapporteur)

20 Jan 2023 · Espaço Europeu de Dados de Saúde

Meeting with Sara Cerdas (Member of the European Parliament)

20 Jan 2023 · Preparatory call for Rethinking the Future of Cancer Care

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro diagnostic medical devices

18 Jan 2023

Meeting with Tomislav Sokol (Member of the European Parliament, Rapporteur)

13 Dec 2022 · European Health Data Space - EHDS

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on liability for defective products

11 Dec 2022

Response to Fitness check of how the Polluter Pays Principle is applied to the environment

8 Dec 2022

Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur)

7 Dec 2022 · Lessons learned on impact of COVID-19 pandemic

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on adapting non-contractual civil liability rules to artificial intelligence (AI Liability Directive)

28 Nov 2022

Meeting with Margrete Auken (Member of the European Parliament, Shadow rapporteur)

24 Nov 2022 · Recast of the UWWTD

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EC) No 1272/2008 as regards hazard classes and criteria for the classification, labelling and packaging of substances and mixtures

18 Oct 2022

Meeting with Pierre Delsaux (Director-General Health Emergency Preparedness and Response Authority)

17 Oct 2022 · EFPIA/EC catch-up on HERA Next meeting of the Joint Cooperation Industrial Forum

Meeting with Kurt Vandenberghe (Cabinet of President Ursula von der Leyen)

10 Oct 2022 · Conc. Commission proposals to revise the entire EU pharmaceutical legislation by the end of the year

Response to Proposal for a Regulation of the European Parliament and the Council on the European Chemicals Agency (ECHA Basic Regulation)

7 Oct 2022

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on standards of quality and safety for substances of human origin intended for human application and repealing Directives 2002/98/EC and 2004/23/EC

8 Sept 2022

Response to Proposal for a Regulation of the European Parliament and of the Council on streamlining chemicals-related data flows, increasing data interoperability, dissemination and re-use across legislation, the notification of commissioned studies, the use of academic studies and the establishment of a mechanism for data generation for the purpose of chemical safety assessments in the context of the European chemicals regulatory framework

10 Aug 2022

Meeting with Kathleen Van Brempt (Member of the European Parliament, Committee chair) and Vaccines Europe

14 Jul 2022 · The current situation of the pandemic and the work of the COVI Committee

Meeting with Stella Kyriakides (Commissioner)

29 Jun 2022 · Exchange of views on the upcoming pharmaceutical legislation

Meeting with Margaritis Schinas (Vice-President) and 1 other attendee

29 Jun 2022 · Pharma Strategy

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EU) No 536/2014 of the European Parliament and of the Council as regards labelling requirements for unauthorised investigational and unauthorised auxiliary medicinal products

28 Jun 2022

Meeting with Véronique Trillet-Lenoir (Member of the European Parliament)

16 Jun 2022 · pharmaceutical strategy

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on harmonised rules on fair access to and use of data (Data Act)

13 May 2022

Meeting with Giorgos Rossides (Cabinet of Commissioner Stella Kyriakides), Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)

11 May 2022 · Exchange of views on the upcoming pharmaceutical strategy.

Response to Commission Communication on a new European Innovation Agenda

10 May 2022

Meeting with Werner Stengg (Cabinet of Executive Vice-President Margrethe Vestager)

6 May 2022 · European Health Data Space, Data Act, Data Governance Act

Response to Proposal for a Regulation of the European Parliament and of the Council on (re-)attribution of scientific and technical work on chemicals to the EU agencies

12 Apr 2022

Response to Commission Communication on the European Care Strategy : strengthening long term care and early childhood education and care

29 Mar 2022

Meeting with Despina Spanou (Cabinet of Vice-President Margaritis Schinas), Maria Luisa Llano Cardenal (Cabinet of Vice-President Margaritis Schinas)

29 Mar 2022 · access to medicines online portal

Response to Commission proposal for a Council Recommendation on strengthened One Health Actions against Antimicrobial Resistance

23 Mar 2022

Meeting with Sandra Gallina (Director-General Health and Food Safety)

16 Mar 2022 ·  EU Pharmaceutical Strategy

Meeting with Stella Kyriakides (Commissioner) and 1 other attendee

14 Mar 2022 · Meeting with EFPIA, Medicines for Europe and European Fine Chemical Group to discuss the security of supply of medicines

Response to Revision of Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC)

22 Feb 2022

Meeting with Caroline Boeshertz (Cabinet of Executive Vice-President Valdis Dombrovskis), Elina Melngaile (Cabinet of Executive Vice-President Valdis Dombrovskis), Kevin Keary (Cabinet of Executive Vice-President Valdis Dombrovskis) and 3 other attendees

26 Oct 2021 · Pharmaceutical sector – trade related issues

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL LAYING DOWN HARMONISED RULES ON ARTIFICIAL INTELLIGENCE (ARTIFICIAL INTELLIGENCE ACT) AND AMENDING CERTAIN UNION LEGISLATIVE ACTS

30 Jul 2021

Meeting with Cyrus Engerer (Member of the European Parliament)

22 Jul 2021 · Pharmaceutical Strategy

Response to Regulation establishing a framework for the use of data in the EU

25 Jun 2021

Meeting with Margaritis Schinas (Vice-President) and 1 other attendee

21 Jun 2021 · Pharmaceutical strategy

Meeting with Margaritis Schinas (Vice-President) and 15 other attendees

16 Jun 2021 · Supply chains for medicines

Meeting with Stella Kyriakides (Commissioner) and 4 other interest representatives

7 Jun 2021 · VTC meeting - Access to Medicines

Response to Revision of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45 EC, and amending Regulation (EC) No 1907/2006 (CLP Regulation)

31 May 2021

Response to Revision of the Regulation (EC) 1907/2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

31 May 2021

Meeting with Caroline Boeshertz (Cabinet of Executive Vice-President Valdis Dombrovskis), Cristina Rueda Catry (Cabinet of Executive Vice-President Valdis Dombrovskis), Michael Hager (Cabinet of Executive Vice-President Valdis Dombrovskis)

17 May 2021 · EU vaccine policy

Response to Proposal for a Council Recommendation on a Pact for Research and Innovation in Europe

12 May 2021

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Meeting with Margaritis Schinas (Vice-President) and 21 other attendees

8 Apr 2021 · Health Union

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on a Single Market For Digital Services (Digital Services Act) and amending Directive 2000/31/EC

31 Mar 2021

Meeting with Despina Spanou (Cabinet of Vice-President Margaritis Schinas), Maria Luisa Llano Cardenal (Cabinet of Vice-President Margaritis Schinas)

25 Mar 2021 · Biopharmaceutical CEO Roundtable

Meeting with Stella Kyriakides (Commissioner) and 2 other interest representatives

5 Mar 2021 · VC Meeting discussion on COVID-19 vaccines export authorisation scheme.

Response to Proposal for a Regulation of the European Parliament and of the Council establishing a European Health Emergency Response Authority (HERA)

23 Feb 2021

Meeting with Sandra Gallina (Director-General Health and Food Safety)

12 Feb 2021 · Phone call with EFPIA

Response to Report from the Commission to the EP and Council on the operation and performance of the Directive 2011/24/EU on the application of patient rights in cross-border healthcare foreseen under Article 17(1) and Article 20(1) & (2) of Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011

9 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on serious cross-border threats to health and repealing Decision No 1082/2013/EU

2 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices

2 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EC) No 851/2004 establishing a European Centre for disease prevention and control

2 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on European data governance (Data Governance Act)

29 Jan 2021

Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products

6 Jan 2021

Response to Green Paper on Ageing

14 Dec 2020

Response to Revision of Directive 2002/98/EC on safety and quality of human blood and blood components and of Directive 2004/23/EC on safety and quality of human tissues and cells and their implementing acts.

11 Dec 2020

Response to Sustainable Products Policy Legislative Initiative

14 Nov 2020

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

6 Nov 2020 · Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic

Meeting with Szabolcs Horvath (Cabinet of Commissioner Olivér Várhelyi)

23 Oct 2020 · Stronger “European health union”

Meeting with Giorgos Rossides (Cabinet of Commissioner Stella Kyriakides), Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides) and MEDICINES FOR EUROPE

22 Oct 2020 · Exchange of views on the upcoming pharmaceutical strategy

Meeting with Despina Spanou (Cabinet of Vice-President Margaritis Schinas), Maria Luisa Llano Cardenal (Cabinet of Vice-President Margaritis Schinas)

20 Oct 2020 · Pharmaceutical strategy

Meeting with Astrid Dentler (Cabinet of Vice-President Dubravka Šuica), Mattia De' Grassi (Cabinet of Vice-President Dubravka Šuica)

15 Oct 2020 · Conference on the Future of Europe Health and industrial policies

Meeting with Nele Eichhorn (Cabinet of Executive Vice-President Margrethe Vestager)

6 Oct 2020 · Pharmaceuticals strategy, Industrial strategy and trade policy issues

Meeting with Stella Kyriakides (Commissioner) and 12 other attendees

30 Sept 2020 · Call with pharmaceutical and medical device supply Chain on COVID-19

Meeting with Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)

23 Sept 2020 · Meeting on the upcoming Pharmaceutical Strategy.

Meeting with Kurt Vandenberghe (Cabinet of President Ursula von der Leyen)

23 Sept 2020 · EU pharmaceutical strategy and the general approach to IP in pharmaceuticals

Meeting with Eszter Batta (Cabinet of Commissioner Thierry Breton)

18 Sept 2020 · Pharmaceutical strategy

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions "Making the most of EU’s innovative potential - An Intellectual Property action plan in support of the EU’s industrial competitiveness"

13 Aug 2020

Response to Legislative framework for the governance of common European data spaces

31 Jul 2020

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

3 Jul 2020

Meeting with Stella Kyriakides (Commissioner)

3 Jul 2020 · VC meeting : Exchange of views on the forthcoming Pharmaceutical Strategy

Response to Digital Services Act: deepening the Internal Market and clarifying responsibilities for digital services

30 Jun 2020

Meeting with Stella Kyriakides (Commissioner) and 9 other attendees

29 Jun 2020 · Call with pharmaceutical and medical device industry associations on COVID-19

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

29 Jun 2020 · Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic

Response to Chemicals strategy for sustainability

19 Jun 2020

Meeting with Giorgos Rossides (Cabinet of Commissioner Stella Kyriakides), Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)

10 Jun 2020 · Webex meeting upon EFPIA’s request to discuss the forthcoming Pharmaceutical Strategy, the evaluation of the EU Orphan Medicinal Products and Paediatrics regulations and the proposed HTA regulation

Meeting with Despina Spanou (Cabinet of Vice-President Margaritis Schinas), Maria Luisa Llano Cardenal (Cabinet of Vice-President Margaritis Schinas)

8 Jun 2020 · Exchange of views on the new pharmaceutical strategy for Europe

Meeting with Anne Bucher (Director-General Health and Food Safety)

5 Jun 2020 · pharmaceutical strategy of the Commission, SWD on the Orphan and Paediatric Regulation

Meeting with Stella Kyriakides (Commissioner) and 8 other interest representatives

29 May 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Virginijus Sinkevičius (Commissioner) and 1 other attendee

19 May 2020 · To discuss EU Pharmaceutical Strategy and EU Chemical Strategy and cooperation on green agenda.

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

15 May 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and 5 other interest representatives

8 May 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

8 May 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Kerstin Jorna (Director-General Internal Market, Industry, Entrepreneurship and SMEs)

5 May 2020 · courtesy call and presentation by EFPIA of their concerns due to COVID crisis and the future of pharmaceutical industry

Response to Report on the application of the General Data Protection Regulation to the European Parliament and the Council

29 Apr 2020

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

29 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and 6 other interest representatives

29 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Jean-Eric Paquet (Director-General Research and Innovation)

24 Apr 2020 · Covid-19

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

23 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and 6 other interest representatives

23 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Response to Communication from the Commission to the European Parliament, the Council and the European Economic and Social Committee on the Action Plan Taking the Customs Union to the Next Level – an Agenda for Action for a strong and modern Customs Union

21 Apr 2020

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

17 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and 5 other interest representatives

9 Apr 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

9 Apr 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and 5 other interest representatives

3 Apr 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 5 other interest representatives

3 Apr 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Anne Bucher (Director-General Health and Food Safety)

2 Apr 2020 · update on Pharma Strategy

Meeting with Thierry Breton (Commissioner) and 5 other interest representatives

27 Mar 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 5 other interest representatives

27 Mar 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and 4 other interest representatives

20 Mar 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 4 other interest representatives

20 Mar 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 4 other interest representatives

13 Mar 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss possible shortages of medicines and medical devices for the Covid-19 outbreak

Response to Commission Communication on Europe’s Beating Cancer Action Plan

3 Mar 2020

Meeting with Renaud Savignat (Cabinet of Commissioner Jutta Urpilainen)

28 Feb 2020 · EFPIA requested a meeting to present their ongoing work

Meeting with Kasia Jurczak (Cabinet of Commissioner Janez Lenarčič)

11 Feb 2020 · Health In humanitarian aid and in crisis management

Meeting with Olympia Neocleous (Cabinet of Commissioner Stella Kyriakides)

11 Feb 2020 · Pharmaceutical strategy

Meeting with Marlene Rosemarie Madsen (Cabinet of Commissioner Elisa Ferreira)

6 Feb 2020 · Medical innovation & Reform policies

Meeting with Dermot Ryan (Cabinet of Commissioner Phil Hogan)

23 Jan 2020 · presentation EFPIA's manifesto

Meeting with Astrid Dentler (Cabinet of Vice-President Dubravka Šuica)

23 Jan 2020 · Integrated health solutions, active ageing, sustainability and quality of healthcare systems, long-term visions on healthcare

Response to Communication on a new Circular Economy Action Plan

20 Jan 2020

Response to Proposal for an EP and Council Regulation on fees charged by the European Medicines Agency (EMA), including remuneration paid to National Competent Authorities (NCAs), for activities related to obtaining and maintaining marketing authorisations for medicinal products for human and veterinary use.

15 Oct 2019

Meeting with Miguel Ceballos Baron (Cabinet of Vice-President Cecilia Malmström)

29 Aug 2019 · Trade in the pharma sector

Meeting with Arunas Ribokas (Cabinet of Commissioner Vytenis Andriukaitis)

29 Aug 2019 · EFPIA position on the EU preliminary list of US products considered for countermeasures

Response to Proposal for a COUNCIL REGULATION for a European Partnership (Joint Undertaking) EU-Africa on global health security to tackle infectious diseases

27 Aug 2019

Response to Proposal for a COUNCIL REGULATION for a European Partnership (Joint Undertaking) for innovative health

27 Aug 2019

Meeting with Timo Pesonen (Acting Director-General Internal Market, Industry, Entrepreneurship and SMEs)

23 Jul 2019 · Present their latest Manifesto and introduce the pharmaceutical companies position towards new Commission

Meeting with Vytenis Andriukaitis (Commissioner) and 2 other attendees

26 Jun 2019 · Access to medicines, shortages, medicines for rare diseases and children

Meeting with Anne Bucher (Director-General Health and Food Safety)

25 Jun 2019 · development of a High-level Forum on Healthcare; the Commission "outcomes" agenda; EU HTA Regulation proposal

Meeting with Jean-Eric Paquet (Director-General Research and Innovation)

23 Apr 2019 · PPPs in health area

Meeting with Jyrki Katainen (Vice-President)

4 Feb 2019 · Supplementary Protection Certificate Manufacturing Waiver in Europe and EFPIA’s priorities in the context of the 2019 institutional changes

Meeting with Anne Bucher (Director-General Health and Food Safety)

3 Dec 2018 · courtesy visit

Meeting with Jean-Eric Paquet (Director-General Research and Innovation)

7 Sept 2018 · Partnesrhips

Meeting with Vytenis Andriukaitis (Commissioner) and 10 other attendees

15 Jun 2018 · HTA

Meeting with Risto Artjoki (Cabinet of Vice-President Jyrki Katainen)

19 Apr 2018 · Competitiveness of the European Pharmaceutical industry

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on health technology assessment and amending Directive 2011/24/EU

30 Mar 2018

Meeting with Michael Hager (Cabinet of Vice-President Günther Oettinger)

21 Mar 2018 · competitiveness of the life science industry in Europe

Meeting with Nils Behrndt (Cabinet of Vice-President Neven Mimica)

19 Mar 2018 · Health in development cooperation

Meeting with Patricia Reilly (Cabinet of Commissioner Tibor Navracsics)

15 Mar 2018 · Research & Innovation policy

Meeting with Maria Asenius (Cabinet of Vice-President Cecilia Malmström), Nele Eichhorn (Cabinet of Vice-President Cecilia Malmström)

8 Feb 2018 · Possible change of EU patent legislation

Meeting with Elżbieta Bieńkowska (Commissioner) and 1 other attendee

30 Jan 2018 · Exchange of views on current topics

Meeting with Irena Andrassy (Cabinet of Vice-President Neven Mimica), Nils Behrndt (Cabinet of Vice-President Neven Mimica)

17 Jan 2018 · Role of pharmaceutical industry in development cooperation

Meeting with Xavier Prats Monné (Director-General Health and Food Safety)

12 Jan 2018 · Discussion on AMR

Response to Joint evaluation of Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products

21 Dec 2017

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

15 Dec 2017 · AMR; Pharma

Meeting with Vytenis Andriukaitis (Commissioner) and 5 other attendees

29 Nov 2017 · Pharmaceutical incentives, antimicrobial resistance

Meeting with Michel Barnier (Head of Task Force Task Force for Relations with the United Kingdom)

27 Oct 2017 · Meeting with the Task Force for the Preparation and Conduct of the Negotiations with the United Kingdom under Article 50 TEU

Response to Communication on Digital transformation of health and care in the context of the DSM

16 Aug 2017

Meeting with Christian Burgsmueller (Cabinet of Vice-President Cecilia Malmström), Maria Asenius (Cabinet of Vice-President Cecilia Malmström)

29 Jun 2017 · Turkey - in breach of rules; Canada - some concerns around implementing legislation.

Response to Communication on a strategic approach to pharmaceuticals in the environment

26 May 2017

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

24 Apr 2017 · Follow-up to COUNCIL conclusions: Impact of the incentives on innovation, availability and accessibility of medicinal products

Response to COMMISSION DIRECTIVE (EU) .../… supplementing Directive 2001/83/EC of the European Parliament and of the Council as regards the principles and guidelines of good manufacturing practice for medicinal products for human use

10 Feb 2017

Response to COMMISSION DELEGATED REGULATION (EU) No …/.. supplementing Regulation (EU) No 536/2014 of the European Parliament and Council by specifying principles of and guidelines for good manufacturing practice for investigational medicinal products for human use and arrangements for inspections

10 Feb 2017

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

31 Jan 2017 · Non Communicable diseases

Meeting with Carlos Moedas (Commissioner) and 1 other attendee

7 Dec 2016 · Meeting with EPFIA'S President, IMI/Innovation Policy

Response to COMMISSION REGULATION (EU) No …/.. amending Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

14 Oct 2016

Meeting with Kevin O'Connell (Cabinet of Commissioner Věra Jourová)

7 Oct 2016 · GDPR

Meeting with Vytenis Andriukaitis (Commissioner) and 1 other attendee

15 Jun 2016 · HTA, AMR, Access to innovative medicines

Meeting with Vytenis Andriukaitis (Commissioner) and 1 other attendee

3 Jun 2016 · AMR, Situation in Ukraine

Meeting with Günther Oettinger (Commissioner)

24 Feb 2016 · Big Data, ehealth

Meeting with Vytenis Andriukaitis (Commissioner) and 1 other attendee

24 Feb 2016 · Access to Medicines, HTA, AMR

Meeting with Cecilia Malmström (Commissioner)

24 Feb 2016 · TTIP, CETA, affordable medicines

Meeting with Nils Behrndt (Cabinet of Vice-President Neven Mimica)

23 Feb 2016 · Access to health care and pharmaceuticals in developing countries

Meeting with Xavier Prats Monné (Director-General Health and Food Safety)

25 Nov 2015 · AMR

Meeting with Maria Asenius (Cabinet of Vice-President Cecilia Malmström), Miguel Ceballos Baron (Cabinet of Vice-President Cecilia Malmström) and Boehringer Ingelheim

19 Nov 2015 · TTIP

Meeting with Arunas Vinciunas (Cabinet of Commissioner Vytenis Andriukaitis)

28 May 2015 · Developments of pharmaceutical industry

Meeting with Jean-Luc Demarty (Director-General Trade)

22 Apr 2015 · Trade relations with US and China

Meeting with Cecile Billaux (Cabinet of Vice-President Cecilia Malmström)

25 Feb 2015 · Trade negotiations and health

Meeting with Maria Asenius (Cabinet of Vice-President Cecilia Malmström), Miguel Ceballos Baron (Cabinet of Vice-President Cecilia Malmström)

10 Feb 2015 · TTIP

Meeting with Antonio Lowndes Marques De Araujo Vicente (Cabinet of Commissioner Carlos Moedas)

10 Feb 2015 · Science and innovation

Meeting with Paolo Berizzi (Cabinet of Vice-President Neven Mimica)

26 Jan 2015 · Anti-biotic resistance within development policy

Meeting with Nils Behrndt (Cabinet of Vice-President Neven Mimica)

23 Jan 2015 · EFPIA engagement in developing countries

Meeting with Giulia Del Brenna (Cabinet of Commissioner Carlos Moedas)

19 Dec 2014 · Innovative Medecines Initiative / Ebola crisis

Meeting with Carlos Moedas (Commissioner)

18 Dec 2014 · European industry’s perspective on the future of EU research and innovation policy